eGenesis, a developer of human-compatible organs that are derived from pigs, raised $191 million in new venture capital funding.
Why it matters: There are over 100,000 people in the U.S. on organ transplant waiting lists, the vast majority of whom are in need of kidneys.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,